Evidence map›Paper›PMID 34753831›Full record

ArticleAging2021

LncRNA MIR31HG is induced by tocilizumab and ameliorates rheumatoid arthritis fibroblast-like synoviocyte-mediated inflammation via miR-214-PTEN-AKT signaling pathway.

Liang Cao, Haifeng Jiang, Jing Yang, Jun Mao, Guofeng Wei, Xiangyun Meng, Hongmei Zang

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 23 citations in OpenAlex.

  1. MIR31HG Modulates IL-4 Secretion by Keratinocytes and M2-Like Macrophage Polarization to Promote Local Immunosuppression in Condyloma Acuminata.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. PTEN: an emerging target in rheumatoid arthritis?Cell communication and signaling : CCS · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Role of ceRNA network in inflammatory cells of rheumatoid arthritis.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Liang CaoSchool of Pharmacy, Anhui Medical University, Hefei, Anhui, China.
Haifeng JiangInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, Anhui, China.
Jing YangSchool of Pharmacy, Anhui Medical University, Hefei, Anhui, China.
Jun MaoDepartment of Pharmacy, The Second People's Hospital of Hefei, Hefei, Anhui, China.
Guofeng WeiDepartment of Emergency, The Second People's Hospital of Hefei, Hefei, Anhui, China.
Xiangyun MengDepartment of Pharmacy, The Second People's Hospital of Hefei, Hefei, Anhui, China.
Hongmei ZangSchool of Pharmacy, Anhui Medical University, Hefei, Anhui, China.
Anhui Medical University · CNThird People's Hospital of Hefei · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblast-like synoviocytes (FLS) obtained from the joint synovium of rheumatoid arthritis (RA) patients exhibit hyperplasia and aggressive inflammatory phenotypes. This study was designed to explore the anti-inflammatory mechanism of IL-6R inhibitor, tocilizumab, in FLS-mediated inflammation in RA from the perspective of non-coding RNAs (ncRNAs). To this end, we sorted primary FLS obtained from the synovium of patients with RA and cultured them

Indexed as

SynoviocytesAntibodies, Monoclonal, HumanizedAnti-Inflammatory AgentsArthritis, RheumatoidCells, CulturedFemaleHumansInflammationMaleMicroRNAsMiddle AgedProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseRNA, Long NoncodingSignal TransductionAntibodies, Monoclonal, HumanizedAnti-Inflammatory Agentslong noncoding RNA MIR31HG, humanMicroRNAsMIRN214 microRNA, humanProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanRNA, Long NoncodingtocilizumabmiR-214MIR31HGPTENRA-FLStocilizumab

Identifiers

PMID34753831
PMCPMC8610144
OpenAlexW3214023532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.